InvestSMART

Austco Healthcare Limited (ASX:AHC)

ALERT: Price-sensitive ASX Announcement for AHC
Current share price for AHC : $0.225 -0.1 (-30.77%)+
Announcement
Release
18 Feb 2026 4:13PM
Price at Release
$0.325
Full Release
download
Summary
Austco Healthcare Limited, a global leader in clinical communications solutions, announced record financial results for the half-year ending 31 December 2025. The company's revenue grew by 31% to $48.2 million, while EBITDA increased by 60% to $8.3 million, reflecting strong organic growth and contributions from newly acquired businesses. The EBITDA margin improved from 14.0% to 17.1%, and the net profit before tax rose by 62.1% to $6.3 million. The company remains debt-free with a cash balance of $15.2 million. Austco's unfilled contracted revenue stands at $47.2 million, providing visibility into future earnings. The company continues to invest in research and development, specifically in its Tacera platform, and has maintained strong market demand, positioning itself for further growth.
Key Points
  • Revenue grew 31% to $48.2 million.
  • EBITDA increased by 60% to $8.3 million.
  • EBITDA margin improved from 14.0% to 17.1%.
  • Net profit before tax rose by 62.1% to $6.3 million.
  • Debt-free with a cash balance of $15.2 million.
  • Unfilled contracted revenue of $47.2 million.
  • Continued investment in research and development.
  • Strong market demand and operational efficiencies.
  • Confidence in sustaining earnings growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.